基于SCORE风险评估系统的欧洲心血管疾病预防指南的局限性。 - Suppr

Suppr

超能文献

Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention.

作者信息

Mortensen Martin Bødtker, Falk Erling

机构信息

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark.

出版信息

Eur Heart J. 2017 Aug 1;38(29):2259-2263. doi: 10.1093/eurheartj/ehw568.

DOI:10.1093/eurheartj/ehw568

PMID:27941016

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5946870/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec59/5946870/2e7d7b7c2b5a/ehw568f1.jpg

相似文献

Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention.

Eur Heart J. 2017 Aug 1;38(29):2259-2263. doi: 10.1093/eurheartj/ehw568.

[Polish forum for prevention guidelines on cardiovascular risk assessment].

Kardiol Pol. 2007 Jan;65(1):100-4.

Screening for high-risk cardiovascular disease: a challenge for the guidelines: comment on "systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check?".

Arch Intern Med. 2010 Jan 11;170(1):40-2. doi: 10.1001/archinternmed.2009.457.

Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.

J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2789-94. doi: 10.1016/j.jacc.2014.04.010. Epub 2014 May 7.

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Eur J Anaesthesiol. 2014 Oct;31(10):517-73. doi: 10.1097/EJA.0000000000000150.

Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.

J Cardiovasc Nurs. 2009 Jan-Feb;24(1):18-20. doi: 10.1097/01.JCN.0000343558.14237.70.

The global cardiovascular crisis: glove up.

J Am Coll Cardiol. 2014 Dec 2;64(21):2300-1. doi: 10.1016/j.jacc.2014.09.027. Epub 2014 Nov 24.

Current European guidelines for management of cardiovascular disease: Is medical treatment in nearly half a population realistic?

Eur J Prev Cardiol. 2018 Jan;25(2):157-163. doi: 10.1177/2047487317738826. Epub 2017 Nov 2.

Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results.

J Am Coll Cardiol. 2014 Aug 5;64(5):520-2. doi: 10.1016/j.jacc.2014.06.1151.

European guidelines on cardiovascular disease and prevention in clinical practice.

Atherosclerosis. 2003 Nov;171(1):145-55. doi: 10.1016/j.atherosclerosis.2003.10.001.

引用本文的文献

Applicability and Risk Stratification of QRISK®, Framingham Risk Score, Systematic Coronary Risk Evaluation (SCORE), and American College of Cardiology/American Heart Association (ACC/AHA) Risk Assessment Tools Among Patients in Taif, Saudi Arabia.

Cureus. 2025 Jun 28;17(6):e86910. doi: 10.7759/cureus.86910. eCollection 2025 Jun.

Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?

Life (Basel). 2024 May 24;14(6):679. doi: 10.3390/life14060679.

A cost-effectiveness evaluation of a high-sensitivity troponin I guided voluntary cardiovascular risk assessment program for asymptomatic women in Croatia.

Int J Cardiol Cardiovasc Risk Prev. 2024 Feb 10;20:200244. doi: 10.1016/j.ijcrp.2024.200244. eCollection 2024 Mar.

Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.

Nutrients. 2023 Mar 18;15(6):1470. doi: 10.3390/nu15061470.

Subendocardial Viability Ratio Predictive Value for Cardiovascular Risk in Hypertensive Patients.

Medicina (Kaunas). 2022 Dec 22;59(1):24. doi: 10.3390/medicina59010024.

Targeting a Silent Disease: Vascular Calcification in Chronic Kidney Disease.

Int J Mol Sci. 2022 Dec 17;23(24):16114. doi: 10.3390/ijms232416114.

Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine.

J Pers Med. 2022 Jul 20;12(7):1180. doi: 10.3390/jpm12071180.

Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.

JAMA Cardiol. 2022 Aug 1;7(8):836-843. doi: 10.1001/jamacardio.2022.1876.

Large health disparities in cardiovascular death in men and women, by ethnicity and socioeconomic status in an urban based population cohort.

EClinicalMedicine. 2021 Aug 29;40:101120. doi: 10.1016/j.eclinm.2021.101120. eCollection 2021 Oct.

Understanding providers' attitudes and key concerns toward incorporating CVD risk prediction into clinical practice: a qualitative study.

BMC Health Serv Res. 2021 Jun 7;21(1):561. doi: 10.1186/s12913-021-06540-y.

本文引用的文献

ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.

Eur Heart J. 2017 Feb 21;38(8):586-594. doi: 10.1093/eurheartj/ehw426.

The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.

Eur Heart J. 2015 Sep 21;36(36):2446-53. doi: 10.1093/eurheartj/ehv251. Epub 2015 Jun 16.

Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.

BMJ Open. 2014 Oct 17;4(10):e005991. doi: 10.1136/bmjopen-2014-005991.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.

Increasing prevalence despite decreasing incidence of ischaemic heart disease and myocardial infarction. A national register based perspective in Denmark, 1980-2009.

Eur J Prev Cardiol. 2015 Feb;22(2):189-95. doi: 10.1177/2047487313509495. Epub 2013 Oct 28.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3.

Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

J Am Coll Cardiol. 2009 Sep 29;54(14):1209-27. doi: 10.1016/j.jacc.2009.07.020.

Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality.

Int J Cardiol. 2010 Sep 3;143(3):385-90. doi: 10.1016/j.ijcard.2009.03.101. Epub 2009 Apr 22.

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Eur Heart J. 2003 Jun;24(11):987-1003. doi: 10.1016/s0195-668x(03)00114-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验